MedTrace Logo

Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias

NCT05860439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 191

Last updated 2023-10-18

No results posted yet for this study

Summary

A long-term follow-up cohort study of patients that were assigned in two previous studies to compare the clinical results of sclerotherapy of telangiectasias and reticular veins of lower limbs using 0.2% polidocanol diluted in 70% hypertonic glucose (PDHG) vs 75% hypertonic glucose (HG) alone.

All women, previously treated as aforementioned, were invited to be reevaluated regarding late maintenance and pigmentation over two years of follow-up.

No new treatments were applied to the cohort.

Conditions

  • Telangiectasis

Interventions

PROCEDURE

Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)

Patients previously treated were reassessed for long-term follow-up.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • UPECLIN HC FM Botucatu Unesp

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2023-05-01
Completion
2023-06-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05860439 on ClinicalTrials.gov